Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Spirax Group plc (LON:SPX), ist nicht der größte Konzern, aber es gab in den letzten Monaten signifikante Kursbewegungen auf dem LSE, mit Höchstständen von UK£79,20 und Tiefstständen von UK£64,35. Einige Kursbewegungen können Investoren eine bessere Gelegenheit bieten, in das Unternehmen zu investieren, und möglicherweise bei einem niedrigeren Preis zu kaufen. Eine Frage ist, ob der aktuelle Handelskurs von UK£68,35 des Mid-Caps tatsächlich den Wert des Unternehmens widerspiegelt oder ob es sich um ein Underperformer handelt, was uns die Gelegenheit gibt, zu kaufen.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Aktien von Spirax Group PLC (SPXSY) haben sich letzte Woche um 8,8% schlechter entwickelt. Ein Hammermuster wurde jedoch im letzten Handelszeitraum gebildet, was bedeuten könnte, dass der Aktienkurs unterstützt wird und ein Trendwende möglich ist. Die Bildung eines Hammermusters gilt als technische Indikation für einen nahenden Tiefpunkt mit abnehmender Verkaufsnachfrage. Aber dies ist nicht der einzige Faktor, der eine bullische Position für den Aktienkurs unterstützt. Auf der fundamentalen Seite hat sich die Einigung unter Wall-Street-Analysten hinsichtlich der Earnings-Erwartungen für dieses Unternehmen erhöht, was seine Chancen auf eine Trendwende verbessert.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

This article first appeared on GuruFocus.

Group Sales Growth: 5% increase, outperforming IP. Adjusted Operating Profit Growth: 6% increase. Group Margin: 20%, up 30 basis points. STS Sales Growth: 1% overall, 3% excluding large projects in China and Korea. STS Margin: 23.5%. ETS Sales Growth: 11% increase. Watson-Marlow Sales Growth: 6% increase. Watson-Marlow Margin: 26.2%, up 160 basis points. Annualized Savings from Restructuring: GBP40 million. Cash Conversion: Improved to 89%. Leverage: Reduced to 1.5 times. Return on Capital Employed: 36%. Return on Invested Capital: 13%. Net Financing Costs: GBP38 million. Effective Tax Rate: 27.3%. Adjusted EPS: 296.3p per share, 3% increase. Full Year Dividend: 17p per share, 3% increase. Net Debt: GBP564.7 million.

Warning! GuruFocus has detected 10 Warning Signs with SPXSY. Is SPXSY fairly valued? Test your thesis with our free DCF calculator.

Release Date: March 10, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Spirax Group PLC (SPXSY) achieved a 5% organic sales growth and a 6% increase in adjusted operating profit, outperforming industrial production (IP). The company maintained a strong group margin of 20%, up 30 basis points, by focusing on pricing and cost discipline. The restructuring program completed in 2025 resulted in annualized savings of GBP40 million, which are being reinvested in future growth. Watson-Marlow division saw a 6% sales growth with margins up 160 basis points to 26.2%, driven by strong demand in Biopharm and Process Industries. Cash conversion improved to 89%, with leverage reducing to 1.5 times, reflecting strong cash discipline.

Negative Points

Geopolitical tensions and tariff volatility negatively impacted large project demand in China and Korea, leading to weak demand in these regions. Currency movements had a negative impact of 3% on sales and 4% on operating profit, posing a challenge to financial performance. The macroeconomic environment remained weak and volatile, with global IP excluding China at only 1.7%, below historic averages. The effective tax rate increased to 27.3%, reflecting a higher profit mix and the absence of one-off benefits from the prior year. The restructuring program incurred a GBP40 million cost, with GBP22 million spent in 2025 and the remaining GBP11 million expected to be spent in 2026.

Q & A Highlights

Q: Can you help us understand the base margin for the ETS division now, excluding legacy contracts? Also, how long will the tailwinds to margins last? A: (Louisa Burdett, CFO) We are confident about the journey to a 20% margin, though it won't be linear over the next two years. There are several factors, including volume demand, legacy project orders, operational improvements, and Semicon demand, that contribute to this. We won't disclose specific numbers for legacy margins, but these are the key elements to consider.

Story Continues

Q: Regarding China and STS, are you still on track for the aftermarket MRO catching up to neutral territory by the end of this year? A: (Nimesh Patel, CEO) We are seeing a moderation of headwinds in large projects. Combined with strong growth in MRO, we expect to reach neutral territory in China either in the second half of 2026 or during 2027. However, recent events like changing tariffs or Middle East conflicts might impact this.

Q: On the GBP40 million investment in growth, how much additional growth do you expect over five years compared to not investing? How are you tracking this growth? A: (Nimesh Patel, CEO) We expect mid-single-digit growth, with last year at 4% and this year at 5% organic growth. These investments will drive higher growth rates. (Louisa Burdett, CFO) Each business has value propositions for these investments, and we track them through planning and reviews. Some digital infrastructure costs are held centrally and will be recharged as commercial benefits come through.

Q: For ETS, can you break out how much of the 11% organic growth in 2025 was due to better execution in North American facilities? What contribution can we expect in 2026? A: (Louisa Burdett, CFO) The North American footprint's throughput increased by 20% year-over-year, contributing significantly to growth. We expect more progress in 2026. (Nimesh Patel, CEO) Strong underlying demand growth across all ETS divisions, including Semicon and Heat Trace, supports this.

Q: For Steam, you're guiding to low single-digit organic growth. Is this volume or price-driven? A: (Nimesh Patel, CEO) We don't disclose the split, but typically our pricing is in line with or slightly ahead of inflation. The focus on solution selling and pricing for value means that volume versus price can be misleading.

Q: Regarding Watson-Marlow, is the business now well-capitalized, and do we return to strong operational gearing in 2026? A: (Louisa Burdett, CFO) We are on track to return to 30% margins in the medium term. High single-digit growth in Watson-Marlow will support this, with ongoing investments in North American facilities being critical for 2026.

Q: How do customers typically respond to extreme energy price volatility, and are you seeing any trends currently? A: (Nimesh Patel, CEO) Customers tend to seek energy efficiency solutions, which benefits us due to our direct sales force and digital solutions. We anticipate increased demand for our solutions during energy price spikes, although capital conservation may impact large projects.

Q: On capital allocation, how comfortable are you with the balance sheet being below the lower end of the leverage range? A: (Nimesh Patel, CEO) Historically, leverage was well below 1x. The 1x mark is a trigger for decisions like buybacks. (Louisa Burdett, CFO) We would consider buybacks if there wasn't an alternative use of capital, but we don't feel constrained by the balance sheet.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Spirax-Sarco Engineering logo

Spirax-Sarco Engineering (LON:SPX) management said the group delivered “good organic growth at high margins” in 2025 despite what it described as a weak and volatile macroeconomic environment, while completing a major restructuring program and maintaining its outlook for mid-single-digit organic growth in 2026.

2025 results: organic growth ahead of industrial production

Group CEO Nimesh Patel said the company outperformed industrial production (IP) with 5% organic sales growth in 2025. On an adjusted basis, operating profit rose 6% and the group adjusted operating margin was 20%, up 30 basis points organically, supported by what management characterized as pricing and cost discipline amid FX and tariff headwinds.

→ Will the Super Mario Movie Make It Showtime for Nintendo Stock?

Group CFO Louisa Burdett said currency movements were a 3% headwind to sales and a 4% headwind to operating profit. She also highlighted lower net financing costs of GBP 38 million versus the prior year, citing lower average net debt, lower floating rates, and cash centralization initiatives. The effective tax rate increased to 27.3%, which she attributed to profit mix and one-off benefits in the prior year. Adjusted EPS was GBP 2.963, up 3%.

The company declared a full-year dividend of GBP 1.70 per share, including a 3% increase in the final dividend, which Burdett said reflected confidence in returning to higher growth and margin levels.

Divisional performance: margin improvement across all three businesses

→ Credo Technologies Hits Bottom: Now Is the Time to Buy

Management said each of the company’s three businesses delivered growth and improved margins in 2025.

Steam Thermal Solutions (STS): Organic sales rose 1%. Patel said geopolitical tension and tariff volatility drove weak demand for large projects, particularly in China and Korea, but headwinds moderated in the second half. The company emphasized offsetting weakness through MRO and “solution sales,” with STS up 3% excluding large projects in China and Korea. STS margin was 23.5%, up 40 basis points organically, supported by manufacturing efficiencies and some restructuring savings. Electric Thermal Solutions (ETS): Organic sales increased 11%, with management pointing to strong demand across all three ETS divisions and operational improvements. Burdett said ETS operating profit rose 12% organically and margin improved 20 basis points to 16.2%. She noted that 2025 margin progression was moderated by fulfillment of legacy orders at Ogden that were not repriced for inflation and initial costs tied to the startup of a new medium voltage facility, but said ETS margin improved during the year with a stronger second half. Watson-Marlow: Organic sales grew 6%, with Patel reiterating the biopharm recovery was “U-shaped.” Management said biopharm demand growth of over 10% supported accelerating sales growth in the second half, while process industries benefited from a reorganization of sales teams around target sectors. Watson-Marlow margin increased 160 basis points to 26.2%, with Burdett citing volume leverage and manufacturing efficiencies.

Story Continues

Restructuring, cash conversion, and balance sheet

Patel said a significant restructuring initiated in January 2025 is now complete, delivering GBP 40 million in annualized savings, “significantly ahead of where we had planned.” Burdett said the restructuring had a GBP 40 million statutory P&L charge, including GBP 7 million of non-cash charges; of the remaining GBP 33 million, the company spent GBP 22 million in cash in 2025 and expects most of the remaining GBP 11 million to be spent in 2026. She said approximately half of the annualized savings were realized in 2025 and are being used to fund investment in areas including sales capability, digital, new product development, systems, and decarbonization.

→ 3 Blue-Chip Stocks Built for a Rotating Market

Cash conversion (operating profit to cash) improved to 89%, which Burdett attributed to higher operating profit and disciplined capital expenditure at 4% of sales, partially offset by a working capital outflow driven mainly by higher receivables from strong year-end sales. Net debt ended the year at GBP 564.7 million, or 1.5x EBITDA, and Burdett said the group comfortably met covenants.

Patel also cited improved returns, with ROCE at 36% and ROIC at 13%, despite FX headwinds.

2026 outlook: mid-single-digit group growth and margin progression

For 2026, Patel said the company anticipates mid-single-digit organic growth and expects operating leverage to drive adjusted operating profit growth ahead of sales. Burdett provided divisional guidance:

Steam: Low single-digit organic sales growth and a slight organic improvement in margin, with growth expected to remain ahead of IP outside China and continued improvement in the trend rate of large orders in China. ETS: High single-digit organic sales growth supported by a strong order book in process heating and momentum in semicon. Burdett said the shipping of legacy orders at Ogden removes a key headwind and the company anticipates “strong margin progress” in 2026, helped by operating leverage and a higher proportion of semicon sales. Watson-Marlow: High single-digit organic sales growth driven by biopharm demand, with process industries again expected to outperform IP. Burdett said operating leverage should support another year of margin progress with basis-point improvement broadly similar to 2025.

Burdett added that corporate costs will be slightly higher than 2025 due to investments in digital services and decarbonization, while underlying PLC support costs remain tightly controlled.

Demand environment, China, semicon, and biopharm trends

Management described 2025 as a year of weakening industrial production expectations, with global IP excluding China at 1.7%. Patel said 2026 global IP excluding China is forecast around 2%, but the company has taken a more conservative view in internal planning given volatility over the last two years. He also noted the Middle East represents about 1% of group sales and said it was “too early” to fully assess impacts on 2026, though the company is preparing for potential supply chain disruption that it currently expects largely in the first half.

On China, Patel said China represented around 15% of STS sales and remained affected by slower capital investment and exposure to large projects. He said China STS sales were down 3% in 2025, improving from a 13% decline in 2024, driven by moderating large-project weakness and double-digit MRO growth across the installed base. Looking ahead, Patel said the company expects capital project demand to stabilize and then increase, with China potentially returning to growth “either in the second half of 2026 or during 2027,” while cautioning that tariffs and geopolitical developments could affect timing.

In semicon, Patel said demand improved with “double-digit growth,” though not back to 2022 peaks. In Watson-Marlow biopharm, he said orders increased by over 10% and in the first half orders exceeded sales for the first time since the 2021 peak, which supported second-half sales and the first year of biopharm sales growth since 2022. He said the recovery broadened in 2025 as OEM demand improved alongside continued end-user strength.

During Q&A, management declined to disclose a specific ETS margin excluding legacy contracts, but reiterated confidence in a path toward 20% ETS margin over time, noting progress would not be linear and that additional operational improvements and pricing actions would take time to embed. Patel also said a large 2025 ETS data center contract would not be a headwind for 2026, though it is not expected to be as growth-accretive as it was in 2025, with longer-term opportunity beyond 2026.

On capital allocation, Patel confirmed a target leverage range of 1x to 1.5x, describing 1x as a trigger to consider actions such as returns of capital, depending on alternative uses of cash. He said future M&A would focus on bolt-on acquisitions in core markets, with discipline around ROIC and earnings growth compared with returning capital to shareholders.

About Spirax-Sarco Engineering (LON:SPX)

Spirax-Sarco Engineering rebrands as Spirax Group On 22 February 2024, Spirax-Sarco Engineering changed its name to Spirax Group which reflects the Company's evolution over many years to a larger and stronger Group of three aligned Businesses with differentiated and complementary capabilities. Our new name respects our history and where we have come from, with who we are today. It creates more distinction between the Group and its Spirax Sarco trading Division (part of Steam Thermal Solutions), providing improved clarity for all stakeholders.

The article "Spirax-Sarco Engineering H2 Earnings Call Highlights" was originally published by MarketBeat.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Zusammenfassung (ca. 500 Wörter)

Der faire Wert von Spirax Group hat eine leichte Erhöhung erfahren, von £76,87 auf £76,93 pro Aktie. Dies spiegelt eine Verschiebung in den Analystenbewertungen wider, die hauptsächlich auf optimistischem Blick in die langfristigen Wachstumsperspektiven des Unternehmens beruht, während gleichzeitig eine vorsichtige Herangehensweise an unmittelbare Gewinne beibehalten wird.

Mehrere große Brokerages haben ihre Meinungen überarbeitet. UBS hat Spirax Group auf eine „Buy“-Empfehlung angehoben, den Kursziel deutlich von 7.500 GBp auf 10.500 GBp erhöht. UBS’s Erhöhung zeigt Vertrauen im nachhaltigen Wachstum des Unternehmens, bezieht sich auf seinen starken Erfolg, operative Exzellenz und einen gewissen Grad an Transparenz. Umgekehrt hat JPMorgan eine „Neutral“-Bewertung mit nur einer geringfügigen Erhöhung des Kursziels von 7.400 GBp auf 7.500 GBp beibehalten. Dies spiegelt Bedenken hinsichtlich der aktuellen Bewertung und potenzieller kurzfristiger Risiken wider, was darauf hindeutet, dass ein Teil der jüngsten positiven Stimmung bereits im Aktienkurs enthalten ist.

Die wichtigsten Änderungen, die den Fair Value Estimate beeinflussen, sind: ein Anstieg der Abzinsungsrate von 8,82 % auf 9,15 %, ein geringfügiger Anstieg der Umsatzwachstumsübersicht von 4,56 % auf 4,57 % und eine marginale Verbesserung der Nettogewinnmarge von 13,12 % auf 13,13 %. Der erwartete zukünftige P/E-Verhältnis ist ebenfalls moderat gestiegen.

Simply Wall St betont die Bedeutung von „Narrativen“ – von Benutzern erstellten Perspektiven, die finanzielle Daten mit der zugrunde liegenden Geschichte eines Unternehmens verbinden. Diese Narrative kombinieren Prognosen, finanzielle Ziele und Fair-Value-Schätzungen in einen klaren Entscheidungsrahmen. Sie sind dynamisch und aktualisieren sich automatisch, wenn neue Informationen über die Simply Wall St Community verfügbar werden.

Der aktuelle Fokus liegt auf mehreren Schlüsselfaktoren, die Spirax Group antreiben: steigende Nachfrage nach Dekarbonisierung, Energieoptimierung und digitalen Lösungen, insbesondere in Asien. Der strategische Wandel des Unternehmens hin zu höherwertigen Dienstleistungen, zusammen mit operativer Neuordnung und Innovation, tragen ebenfalls dazu bei.

Es werden jedoch auch Risiken hervorgehoben, darunter die Abhängigkeit von reifen Märkten, der Zeitpunkt der Technologieübergänge und potenzielle Auswirkungen von Währungsschwankungen.

Simply Wall St betont, dass ihre Analyse auf historischen Daten und Analystenprognosen basiert und eine unvoreingenommene Methodik verwendet. Es wird klar angegeben, dass dies keine Finanzberatung ist und dass ihre Analyse nicht auf individuelle Anlegerziele oder Umstände zugeschnitten ist. Sie konzentrieren sich auf langfristige, fundamentale Datenanalyse und erkennen an, dass sie möglicherweise die neuesten, preisempfindlichen Ankündigungen nicht berücksichtigen.

Do you need any specific aspects of the translation adjusted or expanded upon? Would you like me to focus on a particular element of the text?